These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 12910419)
21. Inhibin expression in ovarian tumors and tumor-like lesions: an immunohistochemical study. Kommoss F; Oliva E; Bhan AK; Young RH; Scully RE Mod Pathol; 1998 Jul; 11(7):656-64. PubMed ID: 9688187 [TBL] [Abstract][Full Text] [Related]
22. Ovarian sex cord-stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin. Deavers MT; Malpica A; Liu J; Broaddus R; Silva EG Mod Pathol; 2003 Jun; 16(6):584-90. PubMed ID: 12808064 [TBL] [Abstract][Full Text] [Related]
23. Comparative immunohistochemical analysis of granulosa and sertoli components in ovarian sex cord-stromal tumors with mixed differentiation: potential implications for derivation of sertoli differentiation in ovarian tumors. Vang R; Herrmann ME; Tavassoli FA Int J Gynecol Pathol; 2004 Apr; 23(2):151-61. PubMed ID: 15084844 [TBL] [Abstract][Full Text] [Related]
24. [Diagnostic value of immunohistochemistry in ovarian sex cord-stromal tumors]. Farah-Klibi F; Ben Slama S; Ben Hamouda S; Sfar R; Koubâa A; Ben Jilani S; Zermani R Tunis Med; 2008 Sep; 86(9):821-6. PubMed ID: 19472783 [TBL] [Abstract][Full Text] [Related]
25. Sertoliform endometrioid carcinomas of the ovary: a clinicopathologic and immunohistochemical study of 13 cases. Ordi J; Schammel DP; Rasekh L; Tavassoli FA Mod Pathol; 1999 Oct; 12(10):933-40. PubMed ID: 10530556 [TBL] [Abstract][Full Text] [Related]
26. Clinical review of 63 cases of sex cord stromal tumors. Zanagnolo V; Pasinetti B; Sartori E Eur J Gynaecol Oncol; 2004; 25(4):431-8. PubMed ID: 15285297 [TBL] [Abstract][Full Text] [Related]
27. Role of adjuvant chemotherapy in the management of non-granulosa cell ovarian sex cord-stromal tumors. Nasioudis D; Orfanelli T; Frey MK; Chapman-Davis E; Caputo TA; Witkin SS; Holcomb K J Gynecol Oncol; 2019 Mar; 30(2):e19. PubMed ID: 30740951 [TBL] [Abstract][Full Text] [Related]
28. [Specificities of sex-cord stromal tumors in children and adolescents]. Thebaud E; Orbach D; Faure-Conter C; Patte C; Hameury F; Kalfa N; Dijoud F; Martelli H; Fresneau B Bull Cancer; 2015 Jun; 102(6):550-8. PubMed ID: 26028491 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of inhibin immunoreactivity in ovarian gonadal stromal tumours and their histological mimics. Stewart CJ; Jeffers MD; Kennedy A Histopathology; 1997 Jul; 31(1):67-74. PubMed ID: 9253627 [TBL] [Abstract][Full Text] [Related]
30. Management of early ovarian cancer: germ cell and sex cord-stromal tumors. Gershenson DM Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S62-72. PubMed ID: 7530680 [TBL] [Abstract][Full Text] [Related]
31. GATA-4 and FOG-2 expression in pediatric ovarian sex cord-stromal tumors replicates embryonal gonadal phenotype: results from the TREP project. Virgone C; Cecchetto G; Ferrari A; Bisogno G; Donofrio V; Boldrini R; Collini P; Dall'Igna P; Alaggio R PLoS One; 2012; 7(9):e45914. PubMed ID: 23029311 [TBL] [Abstract][Full Text] [Related]
32. Unclassified ovarian gonadal stromal tumors. A clinicopathologic study of 32 cases. Seidman JD Am J Surg Pathol; 1996 Jun; 20(6):699-706. PubMed ID: 8651349 [TBL] [Abstract][Full Text] [Related]
33. Ovarian endometrioid carcinomas simulating sex cord-stromal tumors: a study using inhibin and cytokeratin 7. Guerrieri C; Frånlund B; Malmström H; Boeryd B Int J Gynecol Pathol; 1998 Jul; 17(3):266-71. PubMed ID: 9656124 [TBL] [Abstract][Full Text] [Related]
34. Sclerosis in Sex Cord-Stromal Tumors Other Than the Sclerosing Stromal Tumor: A Report of 70 Cases. Devins KM; Young RH Am J Surg Pathol; 2023 Jul; 47(7):774-784. PubMed ID: 37184091 [TBL] [Abstract][Full Text] [Related]
35. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women. Zhang M; Cheung MK; Shin JY; Kapp DS; Husain A; Teng NN; Berek JS; Osann K; Chan JK Gynecol Oncol; 2007 Feb; 104(2):396-400. PubMed ID: 17030354 [TBL] [Abstract][Full Text] [Related]
36. Value of A103 (melan-A) immunostaining in the differential diagnosis of ovarian sex cord stromal tumours. Stewart CJ; Nandini CL; Richmond JA J Clin Pathol; 2000 Mar; 53(3):206-11. PubMed ID: 10823140 [TBL] [Abstract][Full Text] [Related]
37. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis. Chan JK; Zhang M; Kaleb V; Loizzi V; Benjamin J; Vasilev S; Osann K; Disaia PJ Gynecol Oncol; 2005 Jan; 96(1):204-9. PubMed ID: 15589602 [TBL] [Abstract][Full Text] [Related]
38. [Immunohistochemical study on telomerase activity in ovarian sex-cord stromal tumors]. Liu AJ; Li ZJ; Lu YL; Chen LZ; Zhao P Ai Zheng; 2002 Jan; 21(1):87-90. PubMed ID: 12500406 [TBL] [Abstract][Full Text] [Related]
39. Steroidogenic acute regulatory protein is a useful marker for Leydig cells and sex-cord stromal tumors. Dong L; Wang H; Su Z; Niu S; Wang R; Wu L; Chen G Appl Immunohistochem Mol Morphol; 2011 May; 19(3):226-32. PubMed ID: 21217523 [TBL] [Abstract][Full Text] [Related]
40. Management of ovarian and testicular sex cord-stromal tumors in children and adolescents. Schultz KA; Schneider DT; Pashankar F; Ross J; Frazier L J Pediatr Hematol Oncol; 2012 May; 34 Suppl 2():S55-63. PubMed ID: 22525408 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]